Skip to main content

Logo (Actavis) 453 Pill: white , round, 10mm

The pill with imprint Logo (Actavis) 453 (White, Round1) has been identified as Lamotrigine Extended-Release 200 mg and is used for Bipolar Disorder, Lennox-Gastaut Syndrome, Seizure Prevention, Epilepsy, and Seizures. It belongs to the drug class triazine anticonvulsants and is not a controlled substance.

Images for Logo (Actavis) 453

Lamotrigine extended-release 200 mg Logo (Actavis) 453
Lamotrigine extended-release 200 mg Logo (Actavis) 453 Front
Lamotrigine extended-release 200 mg Logo (Actavis) 453 Back

Lamotrigine Extended-Release

Imprint
Logo (Actavis) 453
Strength
200 mg
Color
White
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Triazine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
00228-1453
Inactive Ingredients
hypromelloses, lactose monohydrate, magnesium stearate, methacrylic acid - methyl methacrylate copolymer (1:2), polyethylene glycol 400, silicon dioxide, magnesium silicate, titanium dioxide, triethyl citrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.